Large-scale testing (Phase 3)Study completedNCT00605280
What this trial is testing
A Multi-Center Trial To Evaluate The Safety And Efficacy Of Pegaptanib Sodium(Macugen) Injected Into The Eye Every 6 Weeks For Up To 2 Years For Macular Swelling Associated With Diabetes, With An Open-Label Macugen Year Extension.
Who this might be right for
Macular Edema Associated With Diabetes Mellitus
Pfizer 317